Hybridan Small Cap Feast - 9 October 2024

* A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: None Delistings: Ascential (ASCL.L) delisted from AIM. What’s baking in the oven? ITF announced:*** Potential** Initial Public Offerings: 30th September 2024: Applied Nutriti

Morning Note – 9 October 2024

IXICO - AI powered neuroimaging platform

IXICO is an AI-driven medical imaging analytics company focused on supporting biopharmaceutical companies develop their neurological drug candidates. The key aim of IXICO’s platform is to support pharma in their efforts to develop targeted drugs (beyond the classical markers) and to develop partnerships with various stakeholders to enable post-marketing patient access, payor savings and large data monitoring. The company’s expanded focus is on Alzheimer's, Parkinson's and Huntington's diseases a

Hybridan Small Cap Feast - 14 August 2024

14th August 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: None Delistings: None What’s baking in the oven? ** Our daily digest of news from UK Small Caps If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”. Hybridan Chefs research@hybridan.com Banquet Buffet*** Crossw

Morning Note – 14 August 2024

IXICO - Commercial momentum and operational execution

IXICO has provided a positive trading update for the 12-months to September 2024 (FY24), noting revenues and EBITDA are expected to exceed our current forecasts. FY24E revenues are expected to be between £5.5m and £5.9m versus our forecast £5.2m, while FY24E EBITDA is expected to be improved versus our forecast loss of £2.1m. Cash at the year-end is expected to be improved relative to our £1.4m forecast. Revenues have been supported by new contract wins in the second half, reflecting early indic

Hybridan Small Cap Feast - 5 August 24

5th August 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: What’s baking in the oven? ** Our daily digest of news from UK Small Caps If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”. Hybridan Chefs research@hybridan.com Banquet Buffet*** Clean Invest Afri

Hybridan Small Cap Feast - 19 June 2024

* A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: MC Mining (MCM.L) has left AIM. What’s baking in the oven? ** Potential**** Initial Public Offerings: ITF announced: Media speculation: 17 June 2024: IntelliAM, an artificial intelligence company focused on the consumer goods industry, is preparing to lis

Hybridan Small Cap Feast - 23 May 24

23rd May 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: ITF announced: 7th May: Time To ACT plc, an engineering business focused on technology for the energy transition sector, has announced its intention to seek Admission to t

Morning Note – 23 May 2024

IXICO - Alzheimer’s contract win

IXICO has announced it has signed a contract with the Global Alzheimer’s Platform (GAP) Foundation to support the foundation’s Bio-Hermes-2 trial. The contract is worth over £1m over a 48-month period; however, we believe the value to IXICO will be greater than this ‘headline’ amount due to the increased visibility and wider recognition of the company’s technology within the Alzheimer’s disease clinical development community. IXICO participated and presented data from the initial Bio-Hermes tria

Hybridan Small Cap Feast - 21 May 24

21st May 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: ITF announced: 7th May: Time To ACT plc, an engineering business focused on technology for the energy transition sector, has announced its intention to seek Admission to t

Morning Note – 21 May 2024

IXICO - Tangible traction

IXICO has reported interim results for the 6-months to March 2024. The company generated revenues of £2.5m, down 21% YoY reflecting the challenging market conditions which IXICO has previously discussed. Given the market conditions, the period saw IXICO’s order book decrease. However, the company expects a stronger H2/24 noting turn in market conditions and progress on contracting new business, which should support revenues in H2/24 and beyond. The company has also completed cost reduction progr

Hybridan Small Cap Feast - 13 Mar 2024

13th March 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: Reverse Takeovers: Change of Market: Our daily digest of news from UK Small Caps If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”. Hybridan Chefs